This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

StockCall Research On Health Management Associates And HCA Holdings: Hospitals Brace For Potent Flu Season

LONDON, January 17, 2013 /PRNewswire/ --

As the flu season reaches epidemic level in the U.S. StockCall financial professionals have been studying the trend of some of the major hospital stocks as we believe the current flu season will have an impact on these companies' revenue. After yesterday's market close, our analysts put together an early technical analysis for Health Management Associates Inc. and HCA Holdings Inc. These free reports are just a click away at http://www.stockcall.com/registration

Flu related doctor visits and hospitalizations have been on the rise recently, as a significant number of states in the U.S. have been reporting increased incidences of flu. Not only has the flu season hit harder this year, but it has also arrived earlier. While analysts can agree that nobody likes the flu, its affect on hospitals is being hotly debated. Some are projecting a surge in revenue for companies like Health Management Associates Inc. (NYSE: HMA) and HCA Holdings Inc. (NYSE: HCA) on the basis that hospitals with a high percentage of beds in the states that are being most affected by flu stand to benefit, as volumes should increase. Our technical review on Health Management Associates can be downloaded for free at http://www.StockCall.com/HMA011713.pdf

However, others believe that hospitals may suffer due to an increase in emergency room visits by uninsured individuals, which lowers per patient revenue rates. Health Management Associates and HCA Holdings [ Free Technical Report on HCA] [ 1 ] are scheduled to release their financial reports in February with Health Management already anticipating net revenue of close to $1.48 billion, Adjusted EBITDA expected to be between $253 and $260 million and diluted earnings per share from continuing operations to come in between $0.19 and $0.21.

The focus on flu season may be a welcome change for hospitals, as they have been going through a challenging time due to legislative changes. Same hospital results for a number of industry players have been encouraging of late though, and 2013 could be a positive year for the industry moving forward. For its third quarter, 2012, HCA Holdings announced profits of $360 million due to a 2.1% surge in admissions. Will the flu season be a boon or a bust for HCA on grounds on admissions this time round, the upcoming earnings scheduled for early February will enlighten investors soon enough.

Footer:

  1. HCA Holdings Inc. Technical Analysis [ http://www.StockCall.com/HCAHoldingsInc011713.pdf  ]

About StockCall.com

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,162.99 +121.45 0.67%
S&P 500 2,123.48 +19.28 0.92%
NASDAQ 5,106.5930 +73.8420 1.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs